Subcutaneous injection of furosemide (Furoscix) 20 mg for fluid overload in heart failure

This code represents the administration of 20 mg of Furoscix, a proprietary formulation of furosemide, via subcutaneous injection. Furoscix is a loop diuretic used to treat fluid overload in adult patients with New York Heart Association (NYHA) Class II and III chronic heart failure. It promotes the excretion of excess fluid and electrolytes, thereby reducing symptoms such as edema and dyspnea.

This code is used when a patient receives a 20 mg subcutaneous injection of Furoscix for the management of fluid retention associated with chronic heart failure. Documentation should clearly indicate the drug administered (Furoscix), the dosage (20 mg), the route of administration (subcutaneous), and the medical necessity for its use in a patient with chronic heart failure.

• Ensure the documentation specifies "Furoscix" to differentiate from other furosemide formulations.
• Verify the route of administration is subcutaneous, as other furosemide injections may be intravenous or intramuscular.
• Do not report this code for oral furosemide or other injectable furosemide products.